David L. Herzog - 14 Dec 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Dec 2023
Net transactions value
+$3,010
Form type
4
Filing time
18 Dec 2023, 17:20:50 UTC
Previous filing
04 Oct 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $3,010 +45 +0.2% $66.90 22,762 14 Dec 2023 Direct F1
holding MET Common Stock 87 14 Dec 2023 by David L. Herzog Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.